Creating a new method for editing DNA in mammalian cells without CRISPR
Developing a CRISPR-free mammalian recombineering system
This study is exploring a new way to change DNA in human cells safely and accurately, which could lead to better gene therapies and treatments for genetic disorders.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10910639 on NIH RePORTER |
What this research studies
This research focuses on developing a novel system for manipulating large segments of DNA in mammalian cells without the use of CRISPR technology. The approach aims to enable precise insertions, deletions, and substitutions of DNA without causing harmful double-strand breaks. By utilizing bacterial recombinases, the researchers will optimize this system to enhance its efficiency and effectiveness for various genetic modifications. Patients may benefit from advancements in gene therapy and treatments for genetic disorders as a result of this innovative technology.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic disorders that could potentially be treated through advanced gene editing techniques.
Not a fit: Patients with conditions that do not involve genetic alterations or those who are not candidates for gene therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective gene therapies for patients with genetic disorders.
How similar studies have performed: While CRISPR has been widely studied and applied, this approach using bacterial recombinases represents a novel and untested method in mammalian cells.
Where this research is happening
La Jolla, United States
- Scripps Research Institute, the — La Jolla, United States (Active)
Researchers
- Principal investigator: Miller, Shannon Marie — Scripps Research Institute, the
- Study coordinator: Miller, Shannon Marie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.